According to a new report by Polaris Market Research, the global rare disease genetic testing market was valued at USD 1,242.8 million in 2025 and is projected to reach USD 3,790.38 million by 2034, expanding at a CAGR of 13.20% over the forecast period. Growth is underpinned by rising demand for early disease detection, expanding adoption of personalized medicine, and accelerating...